A Study of VCT220 in Participants With Hypertension and Obesity or Overweight
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 160 participants.
Also called NCT07360275
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 160 participants
- Sponsor
- Vincentage Pharma Co., Ltd
- Registry
-
NCT07360275
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07360275. Randomized; double masking; primary purpose treatment. Start 2026-03-01 (actual); primary completion 2026-10-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of VCT220 in Participants With Hypertension and Obesity or Overweight
- Acronym
- VICTOR-HTN
- Condition
- Hypertension
- Intervention (Drug)
- VCT220 Tablet
- Intervention (Drug)
- VCT220 Placebo Tablet
- Lead sponsor
- Vincentage Pharma Co., Ltd
Record details
- Record id
cardio:ct-nct07360275- Content hash
f3257b598343bf404b1b6888c50ae13d0aae5116cb68a279a0cd61c24cd9806c